These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29554037)

  • 1. Adaptive and platform trials in remote damage control resuscitation.
    Tolles J; Lewis RJ
    J Trauma Acute Care Surg; 2018 Jun; 84(6S Suppl 1):S28-S34. PubMed ID: 29554037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome-adaptive randomization in clinical trials: issues of participant welfare and autonomy.
    Sim J
    Theor Med Bioeth; 2019 Apr; 40(2):83-101. PubMed ID: 30778720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
    Jaki T; Wason JMS
    BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of an adaptive clinical trial to evaluate the efficacy of platelets stored at low temperature in surgical patients.
    Krachey E; Viele K; Spinella PC; Steiner ME; Zantek ND; Lewis RJ
    J Trauma Acute Care Surg; 2018 Jun; 84(6S Suppl 1):S41-S46. PubMed ID: 29521797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familywise error control in multi-armed response-adaptive trials.
    Robertson DS; Wason JMS
    Biometrics; 2019 Sep; 75(3):885-894. PubMed ID: 30714095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiencies of platform clinical trials: A vision of the future.
    Saville BR; Berry SM
    Clin Trials; 2016 Jun; 13(3):358-66. PubMed ID: 26908536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transfused red blood cells for shock and coagulopathy within remote damage control resuscitation.
    Spinella PC; Doctor A
    Shock; 2014 May; 41 Suppl 1():30-4. PubMed ID: 24296434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.
    Mawocha SC; Fetters MD; Legocki LJ; Guetterman TC; Frederiksen S; Barsan WG; Lewis RJ; Berry DA; Meurer WJ
    Clin Trials; 2017 Jun; 14(3):246-254. PubMed ID: 28135827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive trials for tuberculosis: early reflections on theory and practice.
    Montgomery CM
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1091-8. PubMed ID: 27393545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Data Analysis Method for Using Longitudinal Binary Outcome Data from a SMART to Compare Adaptive Interventions.
    Dziak JJ; Yap JRT; Almirall D; McKay JR; Lynch KG; Nahum-Shani I
    Multivariate Behav Res; 2019; 54(5):613-636. PubMed ID: 30663401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?
    Parke T; Marchenko O; Anisimov V; Ivanova A; Jennison C; Perevozskaya I; Song G
    J Biopharm Stat; 2017; 27(3):457-476. PubMed ID: 28281911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive platform trials rather than randomised controlled trials for paediatric sepsis.
    Long E; Davidson A; Lee KJ; Babl FE; George S
    Emerg Med Australas; 2024 Jun; 36(3):488-490. PubMed ID: 38600436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.
    Berry SM; Petzold EA; Dull P; Thielman NM; Cunningham CK; Corey GR; McClain MT; Hoover DL; Russell J; Griffiss JM; Woods CW
    Clin Trials; 2016 Feb; 13(1):22-30. PubMed ID: 26768569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST).
    Myburgh J; Li Q; Heritier S; Dan A; Glass P;
    Crit Care Resusc; 2012 Mar; 14(1):44-52. PubMed ID: 22404061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials.
    Meyer EL; Mesenbrink P; Dunger-Baldauf C; Glimm E; Li Y; König F;
    Pharm Stat; 2022 May; 21(3):671-690. PubMed ID: 35102685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.